baber/WOPTO huggingface dataset:
Patent EP-1255129-A2 (EP)
Inventor: KONO SHIGETOSHI
IPC: G02B1/10
Filed: 2002-04-27
Abstract: A method for manufacturing an optical member by vapor depositing an
antireflective film on a plastic optical member and vapor depositing a water-repellent
thin film over the antireflective film. The vapor deposition of the
water-repellent thin film is conducted by evaporating a fluorine-containing
organic silicon compound in which the plastic optical member does not exceed
the maximum temperature during the vapor deposition of antireflective film.
The heating for evaporation comprises a first stage where the temperature is
raised from an ordinary temperature to the prescribed temperature (1) not
exceeding the starting temperature of vapor deposition of said compound, and
the second stage where the temperature is raised from said prescribed
temperature (1) to the prescribed temperature (2) equal to or higher than said
starting temperature of vapor deposition. The rate of raising temperature of
the first stage of raising temperature is higher than that of the second stage.
Patent EP-1270218-A2 (EP)
Inventor: MIYAKE HIDEO
IPC: G03F7/004
Filed: 2002-06-18
Abstract: A lithographic printing plate precursor comprising a
hydrophilic support, an alkali-soluble layer and provided
on the alkali-soluble layer a recording layer which
contains an infrared ray absorbent, an alkali-soluble resin
and an inhibitor of inhibiting the alkali-soluble resin
from dissolving in an alkali aqueous developer and
increases in the solubility in an alkaline aqueous solution
upon irradiation of infrared light, and a developing method
of the lithographic printing plate precursor with a non-silicate
developer.
Patent EP-1281602-A2 (EP)
Inventor: MARTIN GERD
IPC: B62D21/12
Filed: 2002-06-22
Abstract: The bearer frame has two longitudinal bearers (2) connected by cross-bearers (6o, 6u) and a vertical web (4), and also a upper strip (3o) and a lower strip (3u). At least one longitudinal sector of the bearer frame is in the form of a reinforcing sector (5) for the two webs and four cross-bearers. The cross-bearers are fixed to a strip and a web at their ends.
Patent EP-1275892-A2 (EP)
Inventor: NORDSTROEM LARS INGVAR
IPC: F16L39/00
Filed: 2002-07-01
Abstract: A device for connecting two twin tubes (1, 2) of a
cloth material is constituted by
   a metal bow (3) in the shape of a "figure eight"
arranged in a cloth pocket at the end of a first tube (1),   a distance rod (4) arranged in a cloth pocket at the
end of a separation wall (1C) between the two tube parts
(1A, 1B),   a clamp strap (5), which has a shape corresponding to
that of the metal bow (3) and is to be arranged over the
metal bow in its pocket of the first tube (1) and over the
end of the second tube (2) pulled over the end of the first
tube, and   means (10, 15, 16, 18) associated with the distance
rod (4) for tightening the clamp strap (5) to the metal bow
(3).
Patent EP-1310859-A2 (EP)
Title: Display system
Inventor: ADAMS MICHAEL DEWAYNE
IPC: G06F1/16
Filed: 2002-07-09
Abstract: There is described a display system wherein the system
provides a user with a plurality of displays for view
information from a computer including at least one display
which is body-supported, such as a head-mounted
display. The system reduces the information, which normally
would be displayed in a head-mounted display,
thus reducing a user's dependence on the head-mounted
display.
Patent EP-1295920-A2 (EP)
Inventor: ZUMDOME WILLIAM
IPC: C09D11/16
Filed: 2002-09-20
Abstract: A fluorescent marking stain for marking items is formulated from a resin
present in a concentration of about 1 percent to about 5 percent of the stain, an active
solvent for and compatible with the resin present in a concentration of about 40
percent to about 50 percent of the stain, a dye solvent present in a concentration of
about 20 percent to about 30 percent of the stain, a diluent present in a concentration
of about 10 percent to about 20 percent of the stain, an adhesion promoter present in a
concentration of about 1 percent to about 5 percent of the stain, an optical brightener
present in a concentration of about 1 percent to about 5 percent of the stain and a
fluorescent dye present in a concentration of about 0.2 percent to about 5 percent of
the stain. A marking pen for use with the marking stain is also disclosed.
Patent EP-1319655-A2 (EP)
Title: Improved process for the preparation of (poly-)isocyanates in the gas phase
Inventor: FRIEDRICH MARTIN DR
IPC: C07C265/14
Filed: 2002-12-02
Abstract: Preparation of di- and/or triisocyanates by phosgenation of corresponding di- and/or triamines involves heating the gaseous di- and/or triamines and phosgene separately to 200-600 degrees C, mixing the two in a static mixer with specific geometry and supplying the mixture continuously to a reaction zone without moving parts. <??>Preparation of di- and/or triisocyanates of formula (I) by phosgenation of corresponding di- and/or triamines of formula (II) involves heating gaseous (II) (optionally diluted with inert gas or solvent vapor) and phosgene (III) separately to 200-600 degrees C, mixing the two gaseous starting materials in a static mixer with specific geometry and supplying the mixture continuously to a reaction zone without moving parts. (II) and (III) flow in parallel through a reactor, (II) being supplied through a central nozzle into a slower flow of (III) supplied via the annular space around the nozzle. The ratio of the narrowest nozzle diameter (d) to the reactor diameter (D) is 5-45%. <??>R(NCO)n (I) <??>R(NH2)n (II) <??>R = aliphatic, cycloaliphatic or aromatic hydrocarbyl with up to 15C, provided that at least 2C are present between two NCO groups; and <??>n = 2 or 3 (preferably 2).
Patent EP-1318422-A2 (EP)
Inventor: PARADISO LOUIS ROBERT
IPC: G02B6/43
Filed: 2002-12-04
Abstract: The present invention can provide an optical backplane assembly
including a structural member for supporting a plurality of optical backplane
connectors and a plurality of fiber-optic fabric inter-connectors. Each one of the
plurality of fiber-optic fabric inter-connectors can include a substantially flat body
portion having legs extending outward from the body portion. Each of the legs
can include at least one optical fiber bundle disposed therein and an optical fiber
connector for cooperatively engaging selected ones of the plurality of optical
backplane connectors. Notably, the body portions of the plurality of fiber-optic
fabric inter-connectors can be stacked so as to at least partially overlap one
another.
Patent EP-1296521-A2 (EP)
Inventor: UEDA TOMOHIRO
IPC: H04N7/36
Filed: 1993-01-28
Abstract: In a high-efficiency encoder which performs motion-compensation
prediction, an intra-field is set every n
fields. The presence of a scene change is detected. When a
scene change occurs, a reference picture of motion-compensation
prediction is switched, or the field immediately
after the scene change is set as an intra-field.
Patent EP-1324633-A2 (EP)
Inventor: KUDO YOSHIMI
IPC: H04R9/02
Filed: 2002-12-19
Abstract: A plurality of heat conduction bodies (13) comprising a
metallic material are located with a space held between each other,
and attached with a connection with at least one of a voice coil
bobbin (7) comprising an insulating material and a voice coil (6).
Further, one end of each heat conduction body is connected to a
center cap (12) comprising a metallic material. When the voice
coil generates heat, the heat can be radiated by transmitting it
to the center cap through the heat conduction body. Additionally,
the heat conduction body with a shape of band is attached with
a space held between each other, and the voice coil bobbin is formed
with an insulating material, so that an eddy current caused by
a magnetic field in a magnetic gap (5) can be restrained from
occurring.
Patent EP-1323724-A2 (EP)
Title: Novel ruthenium complexes and process for preparing alcoholic compounds using these
Inventor: KUNIHIKO TSUTSUMI
IPC: C07C31/125
Filed: 2002-12-23
Abstract: [Problem] It is to provide novel ruthenium complexes having an
optically active diphosphine compound, which has asymmetry on
carbon and is easy to synthesize, as the ligand and a process for
preparing optically active alcoholic compounds using said
complexes as the catalysts, wherein said process is the process
for preparing optically active alcoholic compounds, which are
excellent in terms of reactivity, enatioselectivity and the like
in an asymmetric hydrogenation of carbonyl compounds compared with
conventional ruthenium complex catalysts having an optically
active diphosphine compound having the axial chirality or the
asymmetry on carbon as the ligand. 
     [Solution] An optically active ruthenium complex represented by
the general formula (1)
 
   (wherein X and Y, which can be identical to or different from
each other, represent a hydrogen atom or an anion group, R 1  and
R 2 , which can be identical to or different from each other,
represent a chain or cyclic hydrocarbon group of carbon number
1 to 20, which can be substituted, R 3  and R 4 , which can be identical 
to or different from each other, represent a hydrogen atom or a
hydrocarbon group of carbon number 1 to 3, and R 5 , R 6 , R 7  and R 8 ,
which can be identical to or different from one another, represent
a hydrocarbon group of carbon number 1 to 30, which can be
substituted, with the proviso that when X and Y are bromine, R 1 
and R 2  are a methyl group, and when R 3  and R 4  are a hydrogen atom,
at least one of R 5 , R 6 , R 7  and R 8  is not a phenyl group.).
Patent EP-1228969-A2 (EP)
Inventor: NSHIO YOJI
IPC: B31B50/66
Filed: 2002-02-01
Abstract: A process for producing a sealed container from a
tubular blank (41) of square cross section by folding and
sealing a container bottom forming portion of the blank to
form a flat bottom without using a mandrel. The process
includes the step of sealing the bottom
by collapsing an opening edge part of the container bottom
forming portion to a flat form and sealing opposed walls
of the collapsed opening edge part as lapped over each
other to form a straight bottom seal rib (32).
Patent EP-1321784-A2 (EP)
Inventor: BORDER JOHN
IPC: G02B6/42
Filed: 2002-12-09
Abstract: A fiber optic array and method of making same has precision
fiducial marks (13,24) that aid in the alignment of the fiber optic array. The invention
requires forming additional optical features (16,20) adjacent to the fiber optic array that is
used to write fiducial marks on an opposite surface in the medium containing the
fiber optic array. Fiducial marks are formed when a high intensity collimated
beam of light (26) is directed through the optical features onto a treated portion of the
transparent medium. Fiducial accuracies of 1 micron are possible by using this
approach.
Patent EP-1295904-A2 (EP)
Inventor: LIN SHIOW-CHING
IPC: B05D7/24
Filed: 2002-09-16
Abstract: A process for making pigmented PVDF-based powder coatings by coagulation
and powder based coatings made by the process. The process involves blending a
PVDF latex and a water reducible acrylic polymer and pigment dispersion, adding
coagulant to precipitate solid PVDF and pigment associated by ionic interaction with
acrylic polymer binder, separating solids and drying the precipitate. Also, methods for
coating substrates with the powder coating and coated substrates.
Patent EP-1357912-A2 (EP)
Inventor: STRONG H ANDREW
IPC: A61K31/409
Filed: 2002-02-06
Abstract: The invention relates to the selection and treatment of subjects afflicted with occult choroidal neovascular lesions, including subjects with age-related macular degeneration, by use of photo dynamic therapy (PDT).
Patent EP-1364062-A2 (EP)
Inventor: LEVETT LISA JULIA
IPC: C12Q1/6879
Filed: 2002-02-26
Abstract: A method for the diagnosis of aneuploidy of a chromosome in a fetus is provided using the polymerase chain reaction. The method utilises a multiplex PCR assay comprising a plurality of chromosome-specific short tandem repeat markers. The method can be used to diagnose fetal trisomy and monosomy responsible for disease conditions such as Down Syndrome and Turner Syndrome, respectively. The method can also be used to diagnose the presence of other genetic conditions such as cystic fibrosis.
Patent EP-1366179-A2 (EP)
Inventor: DEIMAN BIRGIT ALBERTA LOUISA M
IPC: C12Q1/6865
Filed: 2002-03-05
Abstract: L'invention porte sur un procédé d'amplification fondée sur la transcription afin d'amplifier des cibles d'ADN commençant à partir d'ADN monocaténaire ou bicaténaire éventuellement présents dans un échantillon. Ce procédé consiste: à incuber l'échantillon dans un tampon d'amplification avec au moins une enzyme de restriction capable de couper l'ADN à un endroit de restriction sélectionné, ladite enzyme de restriction créant une extrémité 3' définie sur le/les brin(s) d'ADN, et un promoteur-amorce, ledit promoteur-amorce comprenant une zone 5' comportant la séquence d'un promoteur reconnu par une ARN polymérase dépendant de l'ADN et une zone 3' qui complète l'extrémité 3' définie du brin d'ADN, une seconde amorce possédant la polarité opposée du promoteur-amorce et comprenant l'extrémité 5' de la séquence cible, et dans le cas de l'ADN monocaténaire en tant qu'ADN cible, une amorce de restriction ; à maintenir le mélange de réaction ainsi créé dans des conditions adéquates et pendant une durée suffisante pour que l'enzyme de restriction puisse effectuer une digestion ; à soumettre l'échantillon à un traitement thermique à une température et pendant une durée suffisantes pour désactiver l'enzyme de restriction et/ou transformer un brin double en brin unique ; à ajouter les réactifs suivants dans l'échantillon : une enzyme ayant une activité ADN polymérase dépendant de l'ARN, une enzyme ayant une activité ADN polymérase dépendant de l'ADN, une enzyme ayant une activité H ribonucléase, une enzyme ayant une activité ARN polymérase ; et à maintenir le mélange de réaction ainsi créé dans des conditions adéquates et pendant une durée suffisante pour que l'amplification puisse avoir lieu.
Patent EP-1383924-A2 (EP)
Inventor: KERR WILLIAM G
IPC: C12N15/12
Filed: 2002-04-02
Abstract: The present invention relates to a novel LPS-responsive and Beige-like Anchor gene (lrba), variants of the lrba gene, fragments of the lrba gene, and polypeptides encoded thereby. The subject invention also pertains to lrba interfering RNA, and uses thereof. In another aspect, the present invention also includes methods of inhibiting tumor growth in a patient by suppressing lrba function.
Patent EP-1427377-A2 (EP)
Inventor: BANDER NEIL
IPC: C12N15/09
Filed: 2002-05-30
Abstract: Methods and compositions for treating, preventing, or diagnosing epidermal or dermal disorders, e.g., psoriasis, are disclosed. The methods and compositions of the invention use binding agents, e.g., antibodies, specific for the extracellular domain of human prostate specific membrane antigen (PSMA).
Patent EP-1366000-A2 (EP)
Inventor: HARRIS CAROLINE S
IPC: C23C16/40
Filed: 2002-02-22
Abstract: Methods and articles are disclosed in which a substrate is provided with a photo-induced hydrophilic surface by forming a photo-induced hydrophilic coating on the substrate by spray pyrolysis, chemical vapor deposition, or magnetron sputter vacuum deposition. The coating can have a thickness of 50 Å to 500 Å, a root mean square roughness of less than 5, preferably less than 2, and photocatalytic activity of less than 3.0 x 10?-3 cm-1 min-1¿ ± 2.0 x 10?-3 cm-1 min-1¿. The substrate includes glass substrates, including glass sheets and continuous float glass ribbons.
Patent EP-1416959-A2 (EP)
Inventor: SPROTT G DENNIS
IPC: A61P37/04
Filed: 2002-08-02
Abstract: The invention relates to a liposome comprising a chloroform soluble and extractable total polar lipid of Mycobacterium spp, particularly a chloroform soluble extractable total polar lipid of Mycobacterium spp BCG. The chloroform soluble and extractable polar lipid may comprise at least one of phosphatidylinositol (PI), phosphatidylinositol mannoside (PIM1), phosphatidylinositol dimannoside (PIM2), mono and dipalmitoylated forms of PIM1 and PIM2, phospholipid of 899 m/z, phosphatidylethanolamine and cardiolipid. The liposome may be prepared by drying chloroform soluble and extractable lipid and then hydrating said dried lipid at a temperature of 65 to 75 °C in water or phosphate buffered saline (PBS). The liposome may be used, for example, to activate dendritic cells to secrete cytokines and modulate an immune response in a mammal, or to direct an immune response to confer protection against a pathogen or a cancer.
Patent EP-1412987-A2 (EP)
Inventor: RONNEBERGER REINHARD
IPC: H01L31/0216
Filed: 2002-05-15
Abstract: L'invention concerne un composant optoélectronique servant à transformer un rayonnement électromagnétique en un courant photoélectrique lié à l'intensité. Ce composant comprend un substrat (1) réalisé en particulier selon la technologie CMOS, qui présente une structure à semiconducteurs intégrée (ASIC) et une structure en couches minces, optiquement active, située en amont dans le sens d'incidence de la lumière. Cette structure comprend une couche (9) constituée d'un matériau conducteur transparent et au moins une couche (6, 7, 8) constituée d'un matériau semiconducteur. Ces couches sont placées sur une couche isolante (4) à l'intérieur de laquelle se trouvent des moyens de raccordement (2, 3, 5) servant à établir un contact entre la structure en couches minces, optiquement active, et la structure à semiconducteurs intégrée, placée sur le substrat. L'objectif de l'invention est d'améliorer un tel composant optoélectronique de sorte la liaison électrique entre la couche (9) de matériau conducteur transparent et une borne de potentiel électrique (15) puisse être réalisée de manière techniquement simple. A cet effet, la couche de matériau conducteur transparent peut être reliée à la borne de potentiel (15) placée à l'extérieur de l'ensemble de pixels par l'intermédiaire d'une structure (10, 11, 12, 13) conductrice, formée en outre sur le substrat.
Patent EP-1406851-A2 (EP)
Title: Ceramique expansee a structure poreuse dirigee
Inventor: SVINKA VISVALDIS
IPC: C04B35/447
Filed: 2002-07-12
Abstract: La présente invention concerne des masses céramiques à base d'oxyde d'aluminium/silicate et/ou à base de carbure et/ou à base d'oxyde de zirconium et/ou à base d'hydroxylapatite, qui ont une structure poreuse dirigée, ouverte ou fermée, ainsi qu'un procédé permettant leur préparation. Les masses céramiques conviennent à la réalisation de matériaux de construction, de matériaux ignifuges, d'adjuvants de combustion, de supports de catalyseur et de matériaux de filtrage.
Patent EP-1429705-A2 (EP)
Inventor: KOYAMA TAKAO
IPC: A61F13/15
Filed: 2002-09-12
Abstract: A disposable diaper comprising a liquid permeable topsheet 2, a liquid impermeable backsheet 3, and a liquid retentive absorbent member 4 and having a substantially oblong shape, the absorbent member 4 in the crotch portion having a middle absorbent portion 42 which occupies the middle 3/7 of the width of the absorbent member 4 and side absorbent portions 43 which each occupy the outermost 1/7 of the width of the absorbent member 4, wherein each side absorbent portion 43 has a larger unit absorption capacity than the middle absorbent portion 42, hydrophobic sheets 3 and 21 are disposed on the lateral outer edge of each side absorbent portion 43 to cover from the upper to lower surfaces of the edge, and an elastic member 71 is disposed in the part having each side absorbent portion 43 in the longitudinal direction of the side absorbent portion 43.
Patent EP-1427326-A2 (EP)
Inventor: MASFERRER JAIME
IPC: A61P35/00
Filed: 2002-08-15
Abstract: La présente invention concerne des méthodes de traitement et de prévention d'affections néoplasiques, faisant intervenir des inhibiteurs de la protéine kinase combinés avec des inhibiteurs de la cyclo-oxygénase, et plus particulièrement les inhibiteurs sélectifs de la cyclo-oxygénase-2.
Patent EP-1436398-A2 (EP)
Inventor: JACKSON ROSAMOND
IPC: C12N15/82
Filed: 2002-09-12
Abstract: La présente invention concerne des cellules transgéniques qui ont été transformées avec des acides nucléiques de glucosyltransférase codant des glucosyltransférases qui glucosylent l'acide abscissique, ou des analogues de celles-ci. La présente invention concerne également l'utilisation de ces glucosyltransférases dans des cribles pour agents à activité herbicide et dans la production et/ou le contrôle d'acide abscissique, ou des analogues de celles-ci.
Patent EP-1432990-A2 (EP)
Inventor: NIKLASSON BO
IPC: G01N33/564
Filed: 2002-08-21
Abstract: An isolated nucleic acid molecule is disclosed, including a nucleotide sequence selected from the nucleotide sequence of (a) Ljungan virus 87-012, (b) Ljungan virus 145SL, (c) Ljungan virus 174F, and (d) a fragment of nucleotide sequences (a)-(c). Also disclosed are polypeptides encoded by the isolated nucleic acid, which are useful in preparing vaccines and antibodies to prevent or inhibit conditions caused by Ljungan virus, including diabetes.
Patent EP-1436311-A2 (EP)
Inventor: KANDIMALLA EKAMBAR M
IPC: C12N5/02
Filed: 2002-09-24
Abstract: L'invention concerne l'inhibition et la diminution du taux d'expression de la survivine. L'invention concerne également des méthodes et des oligonucléotides antisens permettant d'inhiber ou de diminuer le taux d'expression de la survivine dans les cellules et de stimuler l'apoptose et la nécrose cellulaire.
Patent EP-1474853-A2 (EP)
Inventor: ETTE BERND
IPC: H01H71/08
Filed: 2002-10-18
Abstract: A power circuit breaker (2) comprises break contacts for main current circuits and a connection device (6) for auxiliary current circuits that interacts with a contact device (7) mounted in a fixed manner. Signaling switches (13) are placed on a withdrawable rack (1), which accommodates the power circuit breaker (2), and are provided for detecting and signaling the position of the power circuit breaker (2) located inside said withdrawable rack (1). The signaling switches (13) are structurally assigned in a direct manner to an interface subassembly (14) that processes signals, which are transmitted out of the contact device (7) and by the signaling switches (13) and to be relayed to a field bus system (12).
Patent EP-1446422-A2 (EP)
Inventor: PETHE KEVIN
IPC: A61K39/04
Filed: 2002-11-18
Abstract: L'invention concerne une séquence peptidique recombinante immunogène méthylée comprenant l'hémagglutinine de liaison à l'héparine (HBHA) mycobactérienne. L'invention concerne également des procédés de préparation, chimiques et enzymatiques, d'une telle séquence, ladite séquence étant préalablement produite sous une forme recombinante non méthylée puis méthylée par modification post-traductionnelle. L'invention concerne en outre des outils, vecteurs et hôtes cellulaires recombinants, pour la mise en oeuvre des procédés enzymatiques de méthylation post-traductionnelle de la HBHA recombinante. L'invention concerne enfin des compositions immunogènes comprenant la HBHA méthylée, native ou recombinante, de telles compositions étant utiles pour la préparation de vaccins contre les infections mycobactériennes.
Patent EP-1329262-A2 (EP)
Inventor: MAHLER PETER
IPC: B01L3/02
Filed: 2003-01-10
Abstract: A pipette comprises a sealing element (12) of an elastically compliant plastic material which has good sealing properties and is molded directly onto the plastic pipette shaft (5) to form a material-bonded joint.  An Independent claim is also included for a method for producing such a pipette.